Literature DB >> 33826406

Zinc pyrithione activates the volume-regulated anion channel through an antioxidant-sensitive mechanism.

Eric E Figueroa1, Jerod S Denton1,2,3.   

Abstract

Leucine-rich repeat-containing 8 (LRRC8) volume-regulated anion channels (VRACs) play important physiological roles in diverse cell types and may represent therapeutic targets for various diseases. To date, however, the pharmacological tools for evaluating the druggability of VRACs have been limited to inhibitors, as no activators of the channel have been reported. We therefore performed a fluorescence-based high-throughput screening (HTS) of 1,184 Food and Drug Administration-approved drugs for compounds that increase VRAC activity. The most potent VRAC potentiator identified was zinc pyrithione (ZPT), which is used commercially as an antifouling agent and for treating dandruff and other skin disorders. In intracellular Yellow Fluorescent Protein YFP(F46L/H148Q/I152L)-quenching assays, ZPT potentiates the rate and extent of swelling-induced iodide influx dose dependently with a half-maximal effective concentration (EC50) of 5.7 µM. Whole cell voltage-clamp experiments revealed that coapplication of hypotonic solution and 30 µM ZPT to human embryonic kidney 293 or human colorectal carcinoma 116 cells increases the rate of swelling-induced VRAC activation by approximately 10-fold. ZPT potentiates swelling-induced VRAC currents after currents have reached a steady state and activates currents in the absence of cell swelling. Neither ZnCl2 nor free pyrithione activated VRAC; however, treating cells with a mixture of ZnCl2 and pyrithione led to robust channel activation. Finally, the effects of ZPT on VRAC were inhibited by reactive oxygen species (ROS) scavenger N-acetylcysteine (NAC) and NAD(P)H oxidase inhibitor diphenyleneiodonium chloride, suggesting the mechanism of action involves ROS generation. The discovery of ZPT as a potentiator/activator of VRAC demonstrates the utility of HTS for identifying small-molecule modulators of VRAC and adds to a growing repertoire of pharmacological tool compounds for probing the molecular physiology and regulation of this important channel.

Entities:  

Keywords:  LRRC8; VSOR; apoptosis; high-throughput screening; reactive oxygen species

Mesh:

Substances:

Year:  2021        PMID: 33826406      PMCID: PMC8285639          DOI: 10.1152/ajpcell.00070.2021

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   5.282


  50 in total

1.  Inhibition of gastric H+,K+-ATPase by 4-(2-butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), an inhibitor of volume-regulated anion channel.

Authors:  Takuto Fujii; Yuji Takahashi; Hiroshi Takeshima; Chisato Saitoh; Takahiro Shimizu; Noriaki Takeguchi; Hideki Sakai
Journal:  Eur J Pharmacol       Date:  2015-08-13       Impact factor: 4.432

2.  A Topical Zinc Ionophore Blocks Tumorigenic Progression in UV-exposed SKH-1 High-risk Mouse Skin.

Authors:  Rebecca Justiniano; Jessica Perer; Anh Hua; Mohammad Fazel; Andrea Krajisnik; Christopher M Cabello; Georg T Wondrak
Journal:  Photochem Photobiol       Date:  2017-07-21       Impact factor: 3.421

3.  Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC.

Authors:  Felizia K Voss; Florian Ullrich; Jonas Münch; Katina Lazarow; Darius Lutter; Nancy Mah; Miguel A Andrade-Navarro; Jens P von Kries; Tobias Stauber; Thomas J Jentsch
Journal:  Science       Date:  2014-04-10       Impact factor: 47.728

4.  Apoptosis in HepG2 cells induced by zinc pyrithione via mitochondrial dysfunction pathway: Involvement of zinc accumulation and oxidative stress.

Authors:  Jiezhang Mo; Derun Lin; Jingzhen Wang; Ping Li; Wenhua Liu
Journal:  Ecotoxicol Environ Saf       Date:  2018-06-15       Impact factor: 6.291

5.  Glutamate-Releasing SWELL1 Channel in Astrocytes Modulates Synaptic Transmission and Promotes Brain Damage in Stroke.

Authors:  Junhua Yang; Maria Del Carmen Vitery; Jianan Chen; James Osei-Owusu; Jiachen Chu; Zhaozhu Qiu
Journal:  Neuron       Date:  2019-04-11       Impact factor: 17.173

6.  Comparative Effects of Chloride Channel Inhibitors on LRRC8/VRAC-Mediated Chloride Conductance.

Authors:  Jonas Friard; Michel Tauc; Marc Cougnon; Vincent Compan; Christophe Duranton; Isabelle Rubera
Journal:  Front Pharmacol       Date:  2017-05-31       Impact factor: 5.810

7.  The LRRC8 volume-regulated anion channel inhibitor, DCPIB, inhibits mitochondrial respiration independently of the channel.

Authors:  Aqeela Afzal; Eric E Figueroa; Sujay V Kharade; Kevin Bittman; Brittany K Matlock; David K Flaherty; Jerod S Denton
Journal:  Physiol Rep       Date:  2019-12

8.  Angiotensin II (AT1) receptors and NADPH oxidase regulate Cl- current elicited by beta1 integrin stretch in rabbit ventricular myocytes.

Authors:  David M Browe; Clive M Baumgarten
Journal:  J Gen Physiol       Date:  2004-09       Impact factor: 4.086

9.  SWELL1 is a glucose sensor regulating β-cell excitability and systemic glycaemia.

Authors:  Chen Kang; Litao Xie; Susheel K Gunasekar; Anil Mishra; Yanhui Zhang; Saachi Pai; Yiwen Gao; Ashutosh Kumar; Andrew W Norris; Samuel B Stephens; Rajan Sah
Journal:  Nat Commun       Date:  2018-01-25       Impact factor: 14.919

10.  LRRC8/VRAC anion channels enhance β-cell glucose sensing and insulin secretion.

Authors:  Till Stuhlmann; Rosa Planells-Cases; Thomas J Jentsch
Journal:  Nat Commun       Date:  2018-05-17       Impact factor: 14.919

View more
  3 in total

Review 1.  Novel Perspective of Cardiovascular Diseases: Volume-Regulatory Anion Channels in the Cell Membrane.

Authors:  Liming Hou; Yan Liu; Chao Sun; Rong Xu; Guihua Cao; Xiaoming Wang
Journal:  Membranes (Basel)       Date:  2022-06-23

2.  Investigating Structural Property Relationships to Enable Repurposing of Pharmaceuticals as Zinc Ionophores.

Authors:  Oisín Kavanagh; Robert Elmes; Finbarr O'Sullivan; John Farragher; Shane Robinson; Gavin Walker
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

Review 3.  A SWELL time to develop the molecular pharmacology of the volume-regulated anion channel (VRAC).

Authors:  Eric E Figueroa; Jerod S Denton
Journal:  Channels (Austin)       Date:  2022-12       Impact factor: 2.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.